share_log

Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525

Benzinga ·  Nov 6, 2023 10:19

Piper Sandler analyst David Westenberg maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $520 to $525.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment